Barclays Maintains Overweight on Syneos Health, Lowers Price Target to $30
Barclays analyst Luke Sergott maintains Syneos Health (NASDAQ:SYNH) with a Overweight and lowers the price target from $60 to $30.
Yelp, Twilio, Atlassian, And Other Big Losers From Friday
U.S. stocks closed higher on Friday, with the Dow Jones surging more than 400 points. Here is the list of some big stocks recording losses in the previous session.
Dow Rises 100 Points; Silver Jumps 7%
U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining over 100 points on Friday.
Looking Into Syneos Health’s Recent Short Interest
Syneos Health's (NASDAQ:SYNH) short percent of float has risen 25.38% since its last report. The company recently reported that it has 1.67 million shares sold short, which is 1.63% of all regular shares that are available for trading.
Stocks That Hit 52-Week Lows On Friday
Friday's session saw 236 companies set new 52-week lows.
Nasdaq Turns Lower; Crude Oil Rises Sharply
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite turning lower on Friday.
Earnings Outlook For Syneos Health
Syneos Health (NASDAQ:SYNH) is set to give its latest quarterly earnings report on Friday, 2022-11-04. Here's what investors need to know before the announcement.
Analysts estimate that Syneos Health will report an earnings per share (EPS) of $1.32.